LY2784544
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LY2784544, covering 2012-07-03 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY2784544 in Participants With Myeloproliferative Neoplasms [Phase 2]